Clinical Trials Directory

Trials / Conditions / Solid Cancer

Solid Cancer

25 registered clinical trials studyying Solid Cancer — 16 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingStudy of ZE94-0605 in Patients With Advanced Solid Tumors, With Dose Expansion Cohorts.
NCT07524140
Eilean TherapeuticsPhase 1
RecruitingUrolithin A in Patients With Previously Untreated Solid Tumors Receiving Immune Checkpoint Inhibitors
NCT07161310
Goethe UniversityN/A
RecruitingTC-G203 for Patients With GPC3-Positive Advanced Solid Tumors
NCT07242417
Beijing GoBroad HospitalEARLY_Phase 1
Not Yet RecruitingPRaG-1 Plus PRaG Therapy in Advanced Solid Tumors: A Prospective Clinical Trial (PRaG 10.0)
NCT07267234
Second Affiliated Hospital of Soochow UniversityPhase 2
RecruitingEvaluation of the Effect of Cordycepin on CD8+ Lymphocytopenia in Patients With Solid Tumors
NCT07258160
Second Affiliated Hospital of Soochow UniversityPhase 2
RecruitingA Study of AK138D1 in Advanced Malignant Tumors
NCT07281326
AkesoPhase 1
Not Yet RecruitingImpact of Interventional Endoscopy on Quality of Life in Patients With Acute Respiratory Distress Due to Tumor
NCT07051161
University Hospital, Grenoble—
Not Yet RecruitingImmune Modulation With PRaG-1 Treatment
NCT07002502
Second Affiliated Hospital of Soochow UniversityPhase 2
RecruitingProof of Concept to Assess the Feasibility of a Decentralised Pathway Coordinated by the Advanced Practice Nur
NCT06797037
Institut Claudius RegaudN/A
Active Not RecruitingSafety and Efficacy of HCB101 in Combination With Multiple Agents in Patients With Advanced Solid Tumors
NCT06771622
FBD Biologics LimitedPhase 1 / Phase 2
RecruitingA Phase I Study of AK138D1 in the Treatment of Advanced Solid Tumors
NCT06730386
AkesoPhase 1
RecruitingImpact of CES1 Genotype on Capecitabine Exposure in Cancer Patients
NCT07114627
Erasmus Medical Center—
RecruitingStudy of Radiology Manipulator Work Validation by the Radiologist
NCT06894082
Institut Paoli-Calmettes—
RecruitingA Study of HS-20124 in Patients with Advanced Solid Tumors
NCT06763159
Hansoh BioMedical R&D CompanyPhase 1
RecruitingA Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Per
NCT06161025
Daiichi SankyoPhase 2 / Phase 3
RecruitingAn Exploratory Clinical Study to Evaluate the Safety, Tolerability, Immune Response and Preliminary Efficacy o
NCT06697665
Suzhou BlueHorse Therapeutics Co., Ltd.EARLY_Phase 1
CompletedRandomized Phase II Study to Evaluate Efficacy of Web-based Patient-reported Outcome (PRO) Application in Soli
NCT07301996
Asan Medical CenterN/A
CompletedA Clinical Study of Regorafenib in Participants Who Have Been Treated in Previous Bayer-sponsored Regorafenib
NCT03890731
BayerPhase 2
UnknownMetaxa Hospital THromboprophylaxis Program in Oncological & Surgical Patients
NCT04248348
Metaxa Hospital—
TerminatedPoly-ICLC (Hiltonol) and Anti-PD1 or Anti-PD-L1
NCT03721679
Oncovir, Inc.Phase 1 / Phase 2
UnknownImmunological Profile of Solid Tumors Sample
NCT03311100
Assistance Publique Hopitaux De Marseille—
CompletedTreatment of Advanced Solid Tumors With TSA-CTL(Tumor Specific Antigen-Induced Cytotoxic T Lymphocytes)
NCT02959905
BGI, ChinaPhase 1
CompletedMetastatic Spinal Bone Marrow Response to Radiation Therapy Using T1 Weighted Dynamic Contrast-Enhanced Perfus
NCT02376127
Memorial Sloan Kettering Cancer Center—
RecruitingElderly CAncer Patient
NCT02884375
Assistance Publique - Hôpitaux de Paris—
CompletedA Study to Evaluate the Effects of Combining Cabazitaxel With Cisplatin Given Every 3 Weeks in Patients With A
NCT00925743
SanofiPhase 1